Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Deficiency
- late filing
- Rules
- 5250(c)(1)
Exact text from the filing
April 16, 2025, INVO Fertility, Inc. (the “Company”), formerly known as NAYA Biosciences, Inc., received a letter (the “Letter”) from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company failed to file its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Filing”), on a timely basis and, as such, no longer satisfies Nasdaq Listing Rule 5250(c)(1) (the “Rule”). The Letter has no immediate effect on the listing of the Company’s common stock and the Company’s common stock continues to trade on The Nasdaq Capital M
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
INVO Fertility, Inc.: Company changed its corporate name to INVO Fertility, Inc. via an Amendment to Articles of Incorporation filed with Nevada Secretary of State on April 14, 2025 (effective 2025-04-14).
- Change
- charter amendment
- Effective
- 2025-04-14
Exact text from the filing
On April 14, 2025, the Company changed its corporate name to INVO Fertility, Inc., pursuant to an Amendment to Articles of Incorporation filed with the Nevada Secretary of State on April 14, 2025 (the “Name Change”).
View on SEC.gov